135721-56-1
135721-56-1
Chemical Structure
MDL 29913
- CAS No.: 135721-56-1
- Formula:C40H56N8O6
- Molecular Weight:744.92
IUPAC Name: 3-((2S,5S,8S,17S)-5-((1H-indol-3-yl)methyl)-8-benzyl-14,17-diisobutyl-16-methyl-3,6,9,12,18-pentaoxo-1,4,7,10,13,16-hexaazacyclooctadecan-2-yl)propanamide
InChIKey: MXTQADLHXBWSHJ-AECRZBRVSA-N
SMILES: O=C(N[C@H](C(NCC(NC(CN([C@H](C(N[C@H](C(N1)=O)CCC(N)=O)=O)CC(C)C)C)CC(C)C)=O)=O)CC2=CC=CC=C2)[C@@H]1CC3=CNC4=CC=CC=C34
Biological Activity: MDL 29913, a cyclic pseudopeptide, is a competitive NK2 tachykinin receptor selective antagonist, with a pA2 of 8.66[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
MDL 29913 | MDL 29913, a cyclic pseudopeptide, is a competitive NK2 tachykinin receptor selective antagonist, with a pA2 of 8.66. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
